Posttranscriptional Mechanisms Regulating the Inflammatory Response

Advances in Immunology

Volumn 89, Issue , 2006, Pages 1-37

  Stoecklin, Georg ^a   Anderson, Paul ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AJULEMIC ACID; ANGIOGENIC FACTOR; CHEMOKINE; COLLAGENASE 3; CYCLOOXYGENASE 2; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENZYME; GAMMA INTERFERON; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PROTEIN; PROTEINASE; RADICICOL; TETRACYCLINE DERIVATIVE; THALIDOMIDE; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTHRITIS; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; KNOCKOUT MOUSE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; RNA DEGRADATION; RNA STABILITY; RNA TRANSLATION; SINGLE DRUG DOSE; TERATOGENICITY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

ANIMALS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 33646183274     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(05)89001-7     Document Type: Review

References (213)

1. Akashi M., Loussararian A.H., Adelman D.C., Saito M., and Koeffler H.P. Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. Stimulation and regulation. J. Clin. Invest. 85 (1990) 121-129
2. Anderson P., and Kedersha N. Stressful initiations. J. Cell Sci. 115 (2002) 3227-3234
3. Anderson P., and Kedersha N. Visibly stressed: The role of eIF2, TIA-1, and stress granules in protein translation. Cell Stress Chaperones 7 (2002) 213-221
4. Antic D., and Keene J.D. Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am. J. Hum. Genet. 61 (1997) 273-278
5. Atasoy U., Curry S.L., Lopez de Silanes I., Shyu A.B., Casolaro V., Gorospe M., and Stellato C. Regulation of eotaxin gene expression by TNF-alpha and IL-4 through mRNA stabilization: Involvement of the RNA-binding protein HuR. J. Immunol. 171 (2003) 4369-4378
6. Bakheet T., Williams B.R., and Khabar K.S. ARED 2.0: An update of AU-rich element mRNA database. Nucleic Acids Res. 31 (2003) 421-423
7. Bamba S., Andoh A., Yasui H., Makino J., Kim S., and Fujiyama Y. Regulation of IL-11 expression in intestinal myofibroblasts: Role of c-Jun AP-1- and MAPK-dependent pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G529-G538
8. Beckwith J.R. Regulation of the lac operon. Recent studies on the regulation of lactose metabolism in Escherichia coli support the operon model. Science 156 (1967) 597-604
9. Bickel M., Cohen R.B., and Pluznik D.H. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells. J. Immunol. 145 (1990) 840-845
10. Bidinger B., Torres R., Rossetti R.G., Brown L., Beltre R., Burstein S., Lian J.B., Stein G.S., and Zurier R.B. Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes. Clin. Immunol. 108 (2003) 95-102
11. Biswas R., Datta S., Gupta J.D., Novotny M., Tebo J., and Hamilton T.A. Regulation of chemokine mRNA stability by lipopolysaccharide and IL-10. J. Immunol. 170 (2003) 6202-6208
12. Blackshear P.J. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem. Soc. Trans. 30 (2002) 945-952
13. Blackshear P.J., Lai W.S., Kennington E.A., Brewer G., Wilson G.M., Guan X., and Zhou P. Characteristics of the interaction of a synthetic human tristetraprolin tandem zinc finger peptide with AU-rich element-containing RNA substrates. J. Biol. Chem. 278 (2003) 19947-19955
14. Blackshear P.J., Phillips R.S., Vazquez-Matias J., and Mohrenweiser H. Polymorphisms in the genes encoding members of the tristetraprolin family of human tandem CCCH zinc finger proteins. Prog. Nucleic Acid Res. Mol. Biol. 75 (2003) 43-68
15. Bogdan C., Paik J., Vodovotz Y., and Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J. Biol. Chem. 267 (1992) 23301-23308
16. Brewer G. An A+U-rich element RNA-binding factor regulates c-myc stability in vitro. Mol. Cell. Biol. 11 (1991) 2460-2466
17. Briata P., Ilengo C., Corte G., Moroni C., Rosenfeld M.G., Chen C.Y., and Gherzi R. The Wnt/beta-catenin->Pitx2 pathway controls the turnover of Pitx2 and other unstable mRNAs. Mol. Cell 12 (2003) 1201-1211
18. Brook M., Sully G., Clark A.R., and Saklatvala J. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Lett. 483 (2000) 57-61
19. Brown C.Y., Lagnado C.A., and Goodall G.J. A cytokine mRNA-destabilizing element that is structurally and functionally distinct from A + U-rich elements. Proc. Natl. Acad. Sci. USA 93 (1996) 13721-13725
20. Brown C.Y., Lagnado C.A., Vadas M.A., and Goodall G.J. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J. Biol. Chem. 271 (1996) 20108-20112
21. Bufler P., Gamboni-Robertson F., Azam T., Kim S.H., and Dinarello C.A. Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem. J. 381 (2004) 503-510
22. Calabrese L., and Fleischer A.B. Thalidomide: Current and potential clinical applications. Am. J. Med. 108 (2000) 487-495
23. Cao H., Tuttle J.S., and Blackshear P.J. Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein. J. Biol. Chem. 279 (2004) 21489-21499
24. Capowski E.E., Esnault S., Bhattacharya S., and Malter J.S. Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J. Immunol. 167 (2001) 5970-5976
25. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., and Cerami A. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83 (1986) 1670-1674
26. Carballo E., and Blackshear P.J. Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome. Blood 98 (2001) 2389-2395
27. Carballo E., Cao H., Lai W.S., Kennington E.A., Campbell D., and Blackshear P.J. Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J. Biol. Chem. 276 (2001) 42580-42587
28. Carballo E., Lai W.S., and Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281 (1998) 1001-1005
29. Carballo E., Lai W.S., and Blackshear P.J. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95 (2000) 1891-1899
30. Carpenter L., Cordery D., and Biden T.J. Protein kinase Cdelta activation by interleukin-1beta stabilizes inducible nitric-oxide synthase mRNA in pancreatic beta-cells. J. Biol. Chem. 276 (2001) 5368-5374
31. Chen C.-Y.A., and Shyu A.-B. AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem. Sci. 20 (1995) 465-470
32. Chen C.Y., Del Gatto-Konczak F., Wu Z., and Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280 (1998) 1945-1949
33. Chen C.Y., Gherzi R., Andersen J.S., Gaietta G., Jurchott K., Royer H.D., Mann M., and Karin M. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev. 14 (2000) 1236-1248
34. Chen C.Y., Gherzi R., Ong S.E., Chan E.L., Raijmakers R., Pruijn G.J., Stoecklin G., Moroni C., Mann M., and Karin M. AU Binding Proteins Recruit the Exosome to Degrade ARE-Containing mRNAs. Cell 107 (2001) 451-464
35. Chen C.Y., Xu N., and Shyu A.B. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: Different deadenylation kinetics and uncoupling from translation. Mol. Cell. Biol. 15 (1995) 5777-5788
36. Chen C.Y., Xu N., and Shyu A.B. Highly selective actions of HuR in antagonizing AU-rich element-mediated mRNA destabilization. Mol. Cell. Biol. 22 (2002) 7268-7278
37. Chrestensen C.A., Schroeder M.J., Shabanowitz J., Hunt D.F., Pelo J.W., Worthington M.T., and Sturgill T.W. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser 178, a site required for 14-3-3 binding. J. Biol. Chem. 279 (2004) 10174-1084.
38. Cok S.J., Acton S.J., and Morrison A.R. The proximal region of the 3′-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U. J. Biol. Chem. 278 (2003) 36157-36162
39. Coles L.S., Bartley M.A., Bert A., Hunter J., Polyak S., Diamond P., Vadas M.A., and Goodall G.J. A multi-protein complex containing cold shock domain (Y-box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA. Potential role in mRNA stabilization. Eur. J. Biochem. 271 (2004) 648-660
40. Cook A.D., Braine E.L., Campbell I.K., Rich M.J., and Hamilton J.A. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): Requirement for GM-CSF in the effector phase of disease. Arthritis Res. 3 (2001) 293-298
41. Cougot N., Babajko S., and Seraphin B. Cytoplasmic foci are sites of mRNA decay in human cells. J. Cell Biol. 165 (2004) 31-40
42. Cougot N., van Dijk E., Babajko S., and Seraphin B. 'Cap-tabolism'. Trends Biochem. Sci. 29 (2004) 436-444
43. Croft D., McIntyre P., Wibulswas A., and Kramer I. Sustained elevated levels of VCAM-1 in cultured fibroblast-like synoviocytes can be achieved by TNF-alpha in combination with either IL-4 or IL-13 through increased mRNA stability. Am. J. Pathol. 154 (1999) 1149-1158
44. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., and Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107 (2001) 489-499
45. Darnell J.C., Warren S.T., and Darnell R.B. The fragile X mental retardation protein, FMRP, recognizes G-quartets. Ment. Retard. Dev. Disabil. Res. Rev. 10 (2004) 49-52
46. Dean J.L., Brook M., Clark A.R., and Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274 (1999) 264-269
47. Dean J.L., Sully G., Wait R., Rawlinson L., Clark A.R., and Saklatvala J. Identification of a novel AU-rich-element-binding protein which is related to AUF1. Biochem. J. 366 (2002) 709-719
48. Denys A., Udalova I.A., Smith C., Williams L.M., Ciesielski C.J., Campbell J., Andrews C., Kwaitkowski D., and Foxwell B.M. Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages. J. Immunol. 168 (2002) 4837-4845
49. Dever T.E. Gene-specific regulation by general translation factors. Cell 108 (2002) 545-556
50. Dibbens J.A., Miller D.L., Damert A., Risau W., Vadas M.A., and Goodall G.J. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol. Biol. Cell 10 (1999) 907-919
51. Di Marco S., Mazroui R., Dallaire P., Chittur S., Tenenbaum S.A., Radzioch D., Marette A., and Gallouzi I.E. NF-κ B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release. Mol. Cell. Biol. 25 (2005) 6533-6545
52. Dixon D.A., Balch G.C., Kedersha N., Anderson P., Zimmerman G.A., Beauchamp R.D., and Prescott S.M. Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. J. Exp. Med. 198 (2003) 475-481
53. Edwards S., and Hallett M. Seeing the wood for the trees: The forgotten role of neutrophils in rheumatoid arthritis. Immunol. Today 18 (1997) 320-324
54. Esnault S., and Malter J.S. Primary peripheral blood eosinophils rapidly degrade transfected granulocyte-macrophage colony-stimulating factor mRNA. J. Immunol. 163 (1999) 5228-5234
55. Fan X.C., and Steitz J.A. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17 (1998) 3448-3460
56. Fenton M.J., Vermeulen M.W., Clark B.D., Webb A.C., and Auron P.E. Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways. J. Immunol. 140 (1988) 2267-2273
57. Fillman C., and Lykke-Andersen J. RNA decapping inside and outside of processing bodies. Curr. Opin. Cell Biol. 17 (2005) 326-331
58. Ford L.P., Watson J., Keene J.D., and Wilusz J. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev. 13 (1999) 188-201
59. Gao M., Wilusz C.J., Peltz S.W., and Wilusz J. A novel mRNA-decapping activity in HeLa cytoplasmic extracts is regulated by AU-rich elements. EMBO J. 20 (2001) 1134-1143
60. Garnon J., Lachance C., Di Marco S., Hel Z., Marion D., Ruiz M.C., Newkirk M.M., Khandjian E.W., and Radzioch D. Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level. J. Biol. Chem. 280 (2005) 5750-5763
61. Gerber A.P., Herschlag D., and Brown P.O. Extensive association of functionally and cytotopically related mRNAs with Puf family RNA-binding proteins in yeast. PLoS Biol. 2 (2004) E79
62. Gherzi R., Lee K.Y., Briata P., Wegmuller D., Moroni C., Karin M., and Chen C.Y. A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery. Mol. Cell 14 (2004) 571-583
63. Grosset C., Boniface R., Duchez P., Solanilla A., Cosson B., and Ripoche J. In vivo studies of translational repression mediated by the granulocyte-macrophage colony-stimulating factor AU-rich element. J. Biol. Chem. 279 (2004) 13354-13362
64. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23 (2002) 403-408
65. Han J., Brown T., and Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171 (1990) 465-475
66. Harding H., Novoa Y., Zhang H., Zeng R., Wek M., Schapira M., and Ron D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6 (2000) 1099-1108
67. Harding H.P., Zhang Y., Bertolotti A., Zeng H., and Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 5 (2000) 897-904
68. Hodge D.L., Martinez A., Julias J.G., Taylor L.S., and Young H.A. Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control. Mol. Cell. Biol. 22 (2002) 1742-1753
69. Holtmann H., Winzen R., Holland P., Eickemeier S., Hoffmann E., Wallach D., Malinin N.L., Cooper J.A., Resch K., and Kracht M. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol. Cell. Biol. 19 (1999) 6742-6753
70. Houzet L., Morello D., Defrance P., Mercier P., Huez G., and Kruys V. Regulated control by granulocyte-macrophage colony-stimulating factor AU-rich element during mouse embryogenesis. Blood 98 (2001) 1281-1288
71. Hudson B.P., Martinez-Yamout M.A., Dyson H.J., and Wright P.E. Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat. Struct. Mol. Biol. 11 (2004) 257-264
72. Huwiler A., Akool el S., Aschrafi A., Hamada F.M., Pfeilschifter J., and Eberhardt W. ATP potentiates interleukin-1 beta-induced MMP-9 expression in mesangial cells via recruitment of the ELAV protein HuR. J. Biol. Chem. 278 (2003) 51758-51769
73. Iademarco M.F., Barks J.L., and Dean D.C. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J. Clin. Invest. 95 (1995) 264-271
74. Ikeda E., Achen M.G., Breier G., and Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270 (1995) 19761-19766
75. Ingelfinger D., Arndt-Jovin D.J., Luhrmann R., and Achsel T. The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 8 (2002) 1489-1501
76. Jing Q., Huang S., Guth S., Zarubin T., Motoyama A., Chen J., Di Padova F., Lin S.C., Gram H., and Han J. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120 (2005) 623-634
77. Johnson B.A., and Blackwell T.K. Multiple tristetraprolin sequence domains required to induce apoptosis and modulate responses to TNFalpha through distinct pathways. Oncogene 21 (2002) 4237-4246
78. Johnson B.A., Geha M., and Blackwell T.K. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival. Oncogene 19 (2000) 1657-1664
79. Johnson B.A., Stehn J.R., Yaffe M.B., and Blackwell T.K. Cytoplasmic localization of Tristetraprolin involves 14-3-3-dependent and -independent mechanisms. J. Biol. Chem. 277 (2002) 18029-18036
80. Jonsson H., Allen P., and Peng S.L. Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat. Med. 11 (2005) 666-671
81. Kastelic T., Schnyder J., Leutwiler A., Traber R., Streit B., Niggli H., Mac Kenzie A., and Cheneval D. Induction of rapid IL-1 beta mRNA degradation in THP-1 cells mediated through the AU-rich region in the 3′UTR by a radicicol analogue. Cytokine 8 (1996) 751-761
82. Kaufmann W.E., Cohen S., Sun H.T., and Ho G. Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets. Microsc. Res. Tech. 57 (2002) 135-144
83. Kedersha N., and Anderson P. Stress granules: Sites of mRNA triage that regulate mRNA stability and translatability. Biochem. Soc. Trans 30 (2001) 963-969
84. Kedersha N., Chen S., Gilks N., Li W., Miller I.J., Stahl J., and Anderson P. Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules. Mol. Biol. Cell 13 (2002) 195-210
85. Kedersha N., Cho M.R., Li W., Yacono P.W., Chen S., Gilks N., Golan D.E., and Anderson P. Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J. Cell Biol. 151 (2000) 1257-1268
86. Kedersha N.L., Gupta M., Li W., Miller I., and Anderson P. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J. Cell Biol. 147 (1999) 1431-1442
87. Kedersha N., Stoecklin G., Ayodele M., Yacono P., Lykke-Andersen J., Fitzler M.J., Scheuner D., Kaufman R.J., Golan D.E., and Andersen P. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J. Cell Biol. 169 (2005) 871-884
88. Keene J.D., and Tenenbaum S.A. Eukaryotic mRNPs may represent posttranscriptional operons. Mol. Cell 9 (2002) 1161-1167
89. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., and Kollias G. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J. 10 (1991) 4025-4031
90. Kirkwood K., Martin T., Andreadis S.T., and Kim Y.J. Chemically modified tetracyclines selectively inhibit IL-6 expression in osteoblasts by decreasing mRNA stability. Biochem. Pharmacol. 66 (2003) 1809-1819
91. Kishore R., Tebo J.M., Kolosov M., and Hamilton T.A. Cutting edge: Clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J. Immunol. 162 (1999) 2457-2461
92. Koeffler H.P., Gasson J., and Tobler A. Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents. Mol. Cell. Biol. 8 (1988) 3432-3438
93. Kolios G., Valatas V., and Ward S.G. Nitric oxide in inflammatory bowel disease: A universal messenger in an unsolved puzzle. Immunology 113 (2004) 427-437
94. Kollias G. Modeling the function of tumor necrosis factor in immune pathophysiology. Autoimmun. Rev. 3 Suppl. 1 (2004) S24-S25
95. Kontoyiannis D., Boulougouris G., Manoloukos M., Armaka M., Apostolaki M., Pizarro T., Kotlyarov A., Forster I., Flavell R., Gaestel M., Tsichlis P., Cominelli F., and Kollias G. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J. Exp. Med. 196 (2002) 1563-1574
96. Kontoyiannis D., Kotlyarov A., Carballo E., Alexopoulou L., Blackshear P.J., Gaestel M., Davis R., Flavell R., and Kollias G. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J. 20 (2001) 3760-3770
97. Kontoyiannis D., Pasparakis M., Pizarro T.T., Cominelli F., and Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies. Immunity 10 (1999) 387-398
98. Konttinen Y.T., Salo T., Hanemaaijer R., Valleala H., Sorsa T., Sutinen M., Ceponis A., Xu J.W., Santavirta S., Teronen O., and Lopez-Otin C. Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: Localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol. 18 (1999) 401-412
99. Kotlyarov A., Neininger A., Schubert C., Eckert R., Birchmeier C., Volk H.D., and Gaestel M. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1 (1999) 94-97
100. Krishnamoorthy T., Pavitt G.D., Zhang F., Dever T.E., and Hinnebusch A.G. Tight binding of the phosphorylated alpha subunit of initiation factor 2 (eIF2alpha) to the regulatory subunits of guanine nucleotide exchange factor eIF2B is required for inhibition of translation initiation. Mol. Cell. Biol. 21 (2001) 5018-5030
101. Kuhn H., Walther M., and Kuban R.J. Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications. Prostaglandins Other Lipid Mediat. 68-69 (2002) 263-290
102. Kullmann M., Gopfert U., Siewe B., and Hengst L. ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR. Genes Dev. 16 (2002) 3087-3099
103. Lagnado C.A., Brown C.Y., and Goodall G.J. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell. Biol. 14 (1994) 7984-7995
104. Lahti A., Jalonen U., Kankaanranta H., and Moilanen E. c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages. Mol. Pharmacol. 64 (2003) 308-315
105. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Phillips R.S., and Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol. Cell. Biol. 19 (1999) 4311-4323
106. Lai W.S., Carballo E., Thorn J.M., Kennington E.A., and Blackshear P.J. Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA. J. Biol. Chem. 275 (2000) 17827-17837
107. Lai W.S., Kennington E.A., and Blackshear P.J. Tristetraprolin and its family members can promote the cell-free deadenylation of AU-rich element-containing mRNAs by poly(A) ribonuclease. Mol. Cell. Biol. 23 (2003) 3798-3812
108. Lal A., Mazan-Mamczarz K., Kawai T., Yang X., Martindale J.L., and Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 23 (2004) 3092-3102
109. Lasa M., Mahtani K.R., Finch A., Brewer G., Saklatvala J., and Clark A.R. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 20 (2000) 4265-4274
110. Lawlor K.E., Campbell I.K., Metcalf D., O'Donnell K., van Nieuwenhuijze A., Roberts A.W., and Wicks I.P. Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 101 (2004) 11398-11403
111. Levy A.P., Levy N.S., and Goldberg M.A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271 (1996) 2746-2753
112. Levy N.S., Chung S., Furneaux H., and Levy A.P. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273 (1998) 6417-6423
113. Lindsten T., June C.H., Ledbetter J.A., Stella G., and Thompson G.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244 (1989) 339-343
114. Liu J., Valencia-Sanchez M.A., Hannon G.J., and Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell Biol. 7 (2005) 719-723
115. Loflin P., Chen C.Y., and Shyu A.B. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev. 13 (1999) 1884-1897
116. Lopez de Silanes I., Galban S., Martindale J.L., Yang X., Mazan-Mamczarz K., Indig F.E., Falco G., Zhan M., and Gorospe M. Identification and functional outcome of mRNAs associated with RNA-binding protein TIA-1. Mol. Cell. Biol. 25 (2005) 9520-9531
117. Lu J.Y., and Schneider R.J. Tissue distribution of AU-rich mRNA-binding proteins involved in regulation of mRNA decay. J. Biol. Chem. 279 (2004) 12974-12979
118. Lykke-Andersen J., and Wagner E. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev. 19 (2005) 351-361
119. Ma W.-J., Cheng S., Campbell C., Wright A., and Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271 (1996) 8144-8151
120. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1997) 323-350
121. Mahtani K.R., Brook M., Dean J.L., Sully G., Saklatvala J., and Clark A.R. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21 (2001) 6461-6469
122. Mavropoulos A., Sully G., Cope A.P., and Clark A.R. Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells. Blood 105 (2005) 282-288
123. Mazan-Mamczarz K., Galban S., Lopez de Silanes I., Martindale J.L., Atasoy U., Keene J.D., and Gorospe M. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc. Natl. Acad. Sci. USA 100 (2003) 8354-8359
124. Min H., Turck C.W., Nikolic J.M., and Black D.L. A new regulatory protein, KSRP, mediates exon inclusion through an intronic splicing enhancer. Genes Dev. 11 (1997) 1023-1036
125. Ming X.F., Kaiser M., and Moroni C. c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. EMBO J. 17 (1998) 6039-6048
126. Ming X.F., Stoecklin G., Lu M., Looser R., and Moroni C. Parallel and Independent Regulation of Interleukin-3 mRNA Turnover by Phosphatidylinositol 3-Kinase and p38 Mitogen-Activated Protein Kinase. Mol. Cell. Biol. 21 (2001) 5778-5789
127. Mitchell P., and Tollervey D. Musing on the structural organization of the exosome complex. Nat. Struct. Biol. 7 (2000) 843-846
128. Moore B.A., Aznavoorian S., Engler J.A., and Windsor L.J. Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. Biochim. Biophys. Acta 1502 (2000) 307-318
129. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
130. Morales-Ducret J., Wayner E., Elices M.J., Alvaro-Gracia J.M., Zvaifler N.J., and Firestein G.S. Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J. Immunol. 149 (1992) 1424-1431
131. Mukherjee D., Gao M., O'Connor J.P., Raijmakers R., Pruijn G., Lutz C.S., and Wilusz J. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J. 21 (2002) 165-174
132. Mukhopadhyay D., Houchen C.W., Kennedy S., Dieckgraefe B.K., and Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol. Cell 11 (2003) 113-126
133. Muller C.W. DNA recognition by NF kappa B and STAT transcription factors. Ernst Schering Res. Found. Workshop 14 (2001) 3-166
134. Musgrave B.L., Watson C.L., Haeryfar S.M., Barnes C.A., and Hoskin D.W. CD2-CD48 interactions promote interleukin-2 and interferon-gamma synthesis by stabilizing cytokine mRNA. Cell. Immunol. 229 (2004) 1-12
135. Nair A.P., Hahn S., Banholzer R., Hirsch H.H., and Moroni C. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA. Nature 369 (1994) 239-242
136. Neininger A., Kontoyiannis D., Kotlyarov A., Winzen R., Eckert R., Volk H.D., Holtmann H., Kollias G., and Gaestel M. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J. Biol. Chem. 277 (2002) 3065-3068
137. Ogilvie R.L., Abelson M., Hau H.H., Vlasova I., Blackshear P.J., and Bohjanen P.R. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J. Immunol. 174 (2005) 953-961
138. Ostareck D., Ostareck-Lederer A., Shatsky I., and Hentze M. Lipoxygense mRNA silencing in erythroid differentiation: The 3′ UTR regulatory complex controls 60S ribosomal subunit joining. Cell 104 (2001) 281-290
139. Ostareck D.H., Ostareck-Lederer A., Wilm M., Thiele B.J., Mann M., and Hentze M.W. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell 89 (1997) 597-606
140. Parasrampuria D.A., de Boer P., Desai-Krieger D., Chow A.T., and Jones C.R. Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: A first-in-human study. J. Clin. Pharmacol. 43 (2003) 406-413
141. Pargellis C., and Regan J. Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis. Curr. Opin. Investig. Drugs 4 (2003) 566-571
142. Parker R., and Song H. The enzymes and control of eukaryotic mRNA turnover. Nat. Struct. Mol. Biol. 11 (2004) 121-127
143. Pastore S., Mascia F., Mariotti F., Dattilo C., Mariani V., and Girolomoni G. ERK1/2 regulates epidermal chemokine expression and skin inflammation. J. Immunol. 174 (2005) 5047-5056
144. Peng S.S., Chen C.Y., Xu N., and Shyu A.B. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17 (1998) 3461-3470
145. Perez-Sala D., Cernuda-Morollon E., Diaz-Cazorla M., Rodriguez-Pascual F., and Lamas S. Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am. J. Physiol. Renal Physiol. 280 (2001) F466-F473
146. Phillips K., Kedersha N., Shen L., Blackshear P.J., and Anderson P. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc. Natl. Acad. Sci. USA 101 (2004) 2011-2016
147. Piecyk M., Wax S., Beck A.R., Kedersha N., Gupta M., Maritim B., Chen S., Gueydan C., Kruys V., Streuli M., and Anderson P. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J. 19 (2000) 4154-4163
148. Pillinger M., and Abramson S. The neutrophil in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 21 (1995) 691-714
149. Putland R.A., Sassinis T.A., Harvey J.S., Diamond P., Coles L.S., Brown C.Y., and Goodall G.J. RNA destabilization by the granulocyte colony-stimulating factor stem-loop destabilizing element involves a single stem-loop that promotes deadenylation. Mol. Cell. Biol. 22 (2002) 1664-1673
150. Quijada L., Guerra-Giraldez C., Drozdz M., Hartmann C., Irmer H., Ben-Dov C., Cristodero M., Ding M., and Clayton C. Expression of the human RNA-binding protein HuR in Trypanosoma brucei increases the abundance of mRNAs containing AU-rich regulatory elements. Nucleic Acids Res. 30 (2002) 4414-4424
151. Raghavan A., Robison R.L., McNabb J., Miller C.R., Williams D.A., and Bohjanen P.R. HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J. Biol. Chem. 276 (2001) 47958-47965
152. Raijmakers R., Schilders G., and Pruijn G.J. The exosome, a molecular machine for controlled RNA degradation in both nucleus and cytoplasm. Eur. J. Cell Biol. 83 (2004) 175-183
153. Raineri I., Wegmueller D., Gross B., Certa U., and Moroni C. Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res. 32 (2004) 1279-1288
154. Raj N.B., and Pitha P.M. Two levels of regulation of beta-interferon gene expression in human cells. Proc. Natl. Acad. Sci. USA 80 (1983) 3923-3927
155. Ramos S.B., Stumpo D.J., Kennington E.A., Phillips R.S., Bock C.B., Ribeiro-Neto F., and Blackshear P.J. The CCCH tandem zinc-finger protein Zfp36l2 is crucial for female fertility and early embryonic development. Development 131 (2004) 4883-4893
156. Ridley S.H., Dean J.L., Sarsfield S.J., Brook M., Clark A.R., and Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 439 (1998) 75-80
157. Rigby W.F., Roy K., Collins J., Rigby S., Connolly J.E., Bloch D.B., and Brooks S.A. Structure/Function Analysis of Tristetraprolin (TTP): p38 Stress-Activated Protein Kinase and Lipopolysaccharide Stimulation Do Not Alter TTP Function. J. Immunol. 174 (2005) 7883-7893
158. Ristimaki A., Garfinkel S., Wessendorf J., Maciag T., and Hla T. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J. Biol. Chem. 269 (1994) 11769-11775
159. Rodriguez-Pascual F., Hausding M., Ihrig-Biedert I., Furneaux H., Levy A.P., Forstermann U., and Kleinert H. Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J. Biol. Chem. 275 (2000) 26040-26049
160. Rousseau S., Morrice N., Peggie M., Campbell D.G., Gaestel M., and Cohen P. Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs. EMBO J. 21 (2002) 6505-6514
161. Saito K., Chen S., Piecyk M., and Anderson P. TIA-1 regulates the production of tumor necrosis factor alpha in macrophages, but not in lymphocytes. Arthritis Rheum. 44 (2001) 2879-2887
162. Sarkar B., Xi Q., He C., and Schneider R.J. Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol. Cell. Biol. 23 (2003) 6685-6693
163. Schmidlin M., Lu M., Leuenberger S.A., Stoecklin G., Mallaun M., Gross B., Gherzi R., Hess D., Hemmings B.A., and Moroni C. The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B. EMBO J. 23 (2004) 4760-4769
164. Schnitzer T.J., and Hochberg M.C. COX-2-selective inhibitors in the treatment of arthritis. Cleve. Clin. J. Med. 69 Suppl. 1 (2002) SI20-SI30
165. Serhan C.N. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: Emergence of the counterregulatory side. Arch. Immunol. Ther. Exp. (Warsz) 49 (2001) 177-188
166. Shaw G., and Kamen R. A conserved AU sequence from the 3′untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46 (1986) 659-667
167. Sirenko O.I., Lofquist A.K., De Maria C.T., Morris J.S., Brewer G., and Haskill J.S. Adhesion-dependent regulation of an A + U-rich element-binding activity associated with AUF1. Mol. Cell. Biol. 17 (1997) 3898-3906
168. Sood R., Porter A.C., Olsen D.A., Cavener D.R., and Wek R.C. A mammalian homologue of GCN2 protein kinase important for translational control by phosphorylation of eukaryotic initiation factor-2alpha. Genetics 154 (2000) 787-801
169. Stein I., Neeman M., Shweiki D., Itin A., and Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15 (1995) 5363-5368
170. Stoeckle M.Y. Post-transcriptional regulation of gro alpha, beta, gamma, and IL-8 mRNAs by IL-1 beta. Nucleic Acids Res. 19 (1991) 917-920
171. Stoecklin G., Colombi M., Raineri I., Leuenberger S., Mallaun M., Schmidlin M., Gross B., Lu M., Kitamura T., and Moroni C. Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. EMBO J. 21 (2002) 4709-4718
172. Stoecklin G., Hahn S., and Moroni C. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. J. Biol. Chem. 269 (1994) 28591-28597
173. Stoecklin G., Lu M., Rattenbacher B., and Moroni C. A constitutive decay element promotes tumor necrosis factor alpha mRNA degradation via an AU-rich element-independent pathway. Mol. Cell. Biol. 23 (2003) 3506-3515
174. Stoecklin G., Mayo T., and Anderson P. ARE-mRNA degradation requires the 5′-3′ decay pathway. EMBO Rep. (2005) In Press.
175. Stoecklin G., Ming X.F., Looser R., and Moroni C. Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol. Cell. Biol. 20 (2000) 3753-3763
176. Stoecklin G., Stoeckle P., Lu M., Muehlemann O., and Moroni C. Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. RNA 7 (2001) 1578-1588
177. Stoecklin G., Stubbs T., Kedersha N., Wax S., Rigby W.F., Blackwell T.K., and Anderson P. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 23 (2004) 1313-1324
178. Stumpo D.J., Byrd N.A., Phillips R.S., Ghosh S., Maronpot R.R., Castranio T., Meyers E.N., Mishina Y., and Blackshear P.J. Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. Mol. Cell. Biol. 24 (2004) 6445-6455
179. Sundy J.S. COX-2 inhibitors in rheumatoid arthritis. Curr. Rheumatol. Rep. 3 (2001) 86-91
180. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., and Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10 (1999) 39-49
181. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., Schenkman D.I., Gilkeson G.S., Broxmeyer H.E., Haynes B.F., and Blackshear P.J. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4 (1996) 445-454
182. Tran H., Schilling M., Wirbelauer C., Hess D., and Nagamine Y. Facilitation of mRNA deadenylation and decay by the exosome-bound, DExH protein RHAU. Mol. Cell 13 (2004) 101-111
183. van Dijk E., Cougot N., Meyer S., Babajko S., Wahle E., and Seraphin B. Human Dcp2: A catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 21 (2002) 6915-6924
184. van Leyen K., Duvoisin R.M., Engelhardt H., and Wiedmann M. A function for lipoxygenase in programmed organelle degradation. Nature 395 (1998) 392-395
185. Varnum B.C., Ma Q.F., Chi T.H., Fletcher B., and Herschman H.R. The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat. Mol. Cell. Biol. 11 (1991) 1754-1758
186. Vasudevan S., and Peltz S.W. Regulated ARE-mediated mRNA decay in Saccharomyces cerevisiae. Mol. Cell 7 (2001) 1191-1200
187. Vincenti M.P., and Brinckerhoff C.E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: Integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 4 (2002) 157-164
188. Vockerodt M., Pinkert D., Smola-Hess S., Michels A., Ransohoff R.M., Tesch H., and Kube D. The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: Importance of mRNA half-life regulation. Int. J. Cancer 114 (2005) 598-605
189. Voellmy R. Transcriptional regulation of the metazoan stress protein response. Prog. Nucleic Acid Res. Mol. Biol. 78 (2004) 143-185
190. Wagner B.J., De Maria C.T., Sun Y., Wilson G.M., and Brewer G. Structure and genomic organization of the human AUF1 gene: Alternative pre-mRNA splicing generates four protein isoforms. Genomics 48 (1998) 195-202
191. Wang W., Caldwell M.C., Lin S., Furneaux H., and Gorospe M. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J. 19 (2000) 2340-2350
192. Wang Y., Liu C., Storey J., Tibshirani R., Herschlag D., and Brown P. Precision and functional specificity in mRNA decay. Proc. Natl. Acad. Sci. USA 99 (2002) 5860-5865
193. Wernicke D., Schulze-Westhoff C., Brauer R., Petrow P., Zacher J., Gay S., and Gromnica-Ihle E. Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice. Arthritis Rheum. 46 (2002) 64-74
194. Westra J., Doornbos-van der Meer B., de Boer P., van Leeuwen M.A., van Rijswijk M.H., and Limburg P.C. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor. Arthritis Res. Ther. 6 (2004) R384-R392
195. Westra J., Kuldo J.M., van Rijswijk M.H., Molema G., and Limburg P.C. Chemokine production and E-selectin expression in activated endothelial cells are inhibited by p38 MAPK (mitogen activated protein kinase) inhibitor RWJ 67657. Int. Immunopharmacol. 5 (2005) 1259-1269
196. Westra J., Limburg P.C., de Boer P., and van Rijswijk M.H. Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts. Ann. Rheum. Dis. 63 (2004) 1453-1459
197. Whittemore L.-A., and Maniatis T. Postinduction turnoff of beta-interferon gene expression. Mol. Cell. Biol. 64 (1990) 1329-1337
198. Wickens M., Bernstein D.S., Kimble J., and Parker R. A PUF family portrait: 3′UTR regulation as a way of life. Trends Genet. 18 (2002) 150-157
199. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene 18 (1999) 6112-6120
200. Williams L., Bradley L., Smith A., and Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 172 (2004) 567-576
201. Williams L.M., Ricchetti G., Sarma U., Smallie T., and Foxwell B.M. Interleukin-10 suppression of myeloid cell activation-a continuing puzzle. Immunology 113 (2004) 281-292
202. Winzen R., Gowrishankar G., Bollig F., Redich N., Resch K., and Holtmann H. Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol. Cell. Biol. 24 (2004) 4835-4847
203. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C.Y., Shyu A.B., Muller M., Gaestel M., Resch K., and Holtmann H. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18 (1999) 4969-4980
204. Wipke B.T., and Allen P.M. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 167 (2001) 1601-1608
205. Wodnar-Filipowicz A., and Moroni C. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. Proc. Natl. Acad. Sci. USA 87 (1990) 777-781
206. Worthington M.T., Pelo J.W., Sachedina M.A., Applegate J.L., Arseneau K.O., and Pizarro T.T. RNA Binding Properties of the AU-rich Element-binding Recombinant Nup475/TIS11/Tristetraprolin Protein. J. Biol. Chem. 277 (2002) 48558-48564
207. Xu N., Chen C.Y., and Shyu A.B. Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol. Cell. Biol. 21 (2001) 6960-6971
208. Yang L., and Yang Y.C. Regulation of interleukin (IL)-11 gene expression in IL-1 induced primate bone marrow stromal cells. J. Biol. Chem. 269 (1994) 32732-32739
209. Yang Y.H., and Hamilton J.A. Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor. Arthritis Rheum. 44 (2001) 111-119
210. Yu Q., Cok S.J., Zeng C., and Morrison A.R. Translational repression of human matrix metalloproteinases-13 by an alternatively spliced form of T-cell-restricted intracellular antigen-related protein (TIAR). J. Biol. Chem. 278 (2003) 1579-1584
211. Zhang W., Wagner B.J., Ehrenman K., Schaefer A.W., De Maria C.T., Crater D., De Haven K., Long L., and Brewer G. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13 (1993) 7652-7665
212. Zhu W., Brauchle M.A., Di Padova F., Gram H., New L., Ono K., Downey J.S., and Han J. Gene suppression by tristetraprolin and release by the p38 pathway. Am. J. Lung Cell Mol. Physiol. 281 (2001) L499-L508
213. Zubiaga A.M., Belasco J.G., and Greenberg M.E. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell. Biol. 15 (1995) 2219-2230